In recent years, Novogene Europe has systematically integrated state-of-the-art technologies across its service portfolio, ...

Plants produce a wide diversity of compounds. Broadly, these are separated into primary metabolites, which are necessary for ...

ILMN’s forward P/E was 20.75 respectively according to Yahoo Finance. Illumina stands as the dominant force in genetic sequencing, […] Insider Monkey • 8 days ago ILMN +2.23% ...

Illumina’s first quarter results reflected ongoing challenges in the global genomics market, as the company’s performance ...

A panelist discusses the evolving role of prophylactic tocilizumab in reducing cytokine release syndrome during bispecific antibody therapy, enabling outpatient treatment and improving patient ...

The advent of next-generation sequencing has made possible genome analysis at previously unattainable depth. Roche, Illumina and Life Technologies, among others, have developed well-established ...

The heterogeneity of isoform level m 6 A RNA methylation in single cells is unclear. The authors characterize m 6 A at both single-cell and isoform level through ONT long-read sequencing on single ...

The firm hopes that ETX-636's dual mechanism inhibiting mutant PI3Kα will give it an edge over competing products on the market.